Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase III Trial (30906). - de Reijke,T.M.; Kurth,K.H.; Sylvester,R.J. (J Urol, 2005)